Related Experiment Video

Updated: Mar 6, 2026

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.7K

HIF-2α affects proliferation and apoptosis of MG-63 osteosarcoma cells through MAPK signaling

Yuqiang Wang1, Xiaohua Wang2, Xuetao Su1

  • 1Department of Orthopedic Surgery, The Affiliated Hospital of Logistics College of Chinese People's Armed Police Force, Pingjin Hospital, Tianjin 300162, P.R. China.

Molecular Medicine Reports
|March 6, 2017
PubMed

Insights

Knocking down hypoxia-inducible factor (HIF)-2α in osteosarcoma cells reduces cancer cell proliferation and increases apoptosis, likely via the MAPK-p38 signaling pathway.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Osteosarcoma is a primary bone cancer with limited treatment options.
  • Hypoxia-inducible factor (HIF)-2α is implicated in cancer progression.
  • Understanding HIF-2α's role is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the mechanism of hypoxia-inducible factor (HIF)-2α in osteosarcoma cell proliferation and apoptosis.
  • To determine the effect of HIF-2α knockdown on MG-63 cell viability and apoptosis.
  • To explore the involvement of the MAPK-p38 signaling pathway.

Main Methods:

  • Osteosarcoma MG-63 cells were transfected with small interfering RNA (siRNA) targeting HIF-2α.
  • Cell viability was assessed using MTT assay.
  • Apoptosis was measured by flow cytometry.
  • Expression levels of HIF-2α and MAPK-p38 were determined via western blotting.

Main Results:

  • siRNA-mediated knockdown of HIF-2α significantly reduced MG-63 cell viability 48 hours post-transfection.
  • A significant increase in apoptosis was observed in the silenced group compared to controls.
  • The expression of both HIF-2α and MAPK-p38 was significantly decreased in cells with reduced HIF-2α levels (P<0.05).

Conclusions:

  • Knockdown of HIF-2α effectively suppresses osteosarcoma cell proliferation.
  • Reduced HIF-2α expression promotes apoptosis in osteosarcoma cells.
  • The anti-proliferative and pro-apoptotic effects of HIF-2α inhibition are likely mediated through the MAPK-p38 signaling pathway.

More Related Videos

Stimulation of Notch Signaling in Mouse Osteoclast Precursors08:01

Stimulation of Notch Signaling in Mouse Osteoclast Precursors

Published on: February 28, 2017

8.4K
Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.4K

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
8.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.0K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K